Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
doi: 10.1016/S0891-5849(98)00213-5 70 HoJCChan-YeungMHoSPMakJCIpMSOoiGCet al
10.1016/j.mito.2016.06.007 124 YuberoD.O'callaghanM.MonteroR.OrmazabalA.ArmstrongJ.EspinosC.et al
Monpellier, V
Other immunomodulatory approaches aimed at halting type 1 diabetes progression in stage 1 or 2 yielded mixed results and many failed to meet primary clinical endpoints, highlighting the complexity of early intervention in this multifactorial disease [6,7,8]
Continuous monitoring of these contaminants is becoming more critical, especially as regulatory limits evolve
US$ 27.15
US$ 20.35
US$ 25.09
US$ 20.82
US$ 29.01
US$ 24.00
US$ 24.79
US$ 25.68
US$ 24.00
US$ 25.27
